FDA Inspection 1329850 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Jul 31, 2026 in Clifton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Clifton, NJ (United States)